Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- PMID: 32032529
- PMCID: PMC7137985
- DOI: 10.1016/S0140-6736(20)30304-4
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Erratum in
-
Department of Error.Lancet. 2020 Jun 20;395(10241):1906. doi: 10.1016/S0140-6736(20)31376-3. Lancet. 2020. PMID: 32563374 Free PMC article. No abstract available.
Figures

Comment in
-
COVID-19: combining antiviral and anti-inflammatory treatments.Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27. Lancet Infect Dis. 2020. PMID: 32113509 Free PMC article. No abstract available.
References
-
- Gruber CC, Steinkellner G. Wuhan coronavirus 2019-nCoV—what we can find out on a structural bioinformatics level. Jan 23, 2020. https://innophore.com/2019-ncov/
-
- Segler MHS, Preuss M, Waller P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555:604–610. - PubMed
-
- Zhao Y, Zhao Z, Wang Y. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020 DOI:https://doi.19985 published online Jan 26.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases